2-166013820-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PM1PM5PP2PP3_ModeratePP5BS2
The NM_001165963.4(SCN1A):c.3629C>T(p.Thr1210Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1210K) has been classified as Pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN1A | NM_001165963.4 | c.3629C>T | p.Thr1210Met | missense_variant | 21/29 | ENST00000674923.1 | |
LOC102724058 | NR_110598.1 | n.176-1793G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.3629C>T | p.Thr1210Met | missense_variant | 21/29 | NM_001165963.4 | P4 | ||
SCN1A-AS1 | ENST00000651574.1 | n.193-1793G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151610Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250842Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135546
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460526Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726580
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151610Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74038
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This missense change has been observed in individuals with clinical features of SCN1A-related conditions (PMID: 28202706; Invitae). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1210 of the SCN1A protein (p.Thr1210Met). This variant is present in population databases (rs121918738, gnomAD 0.01%). ClinVar contains an entry for this variant (Variation ID: 658067). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function. This variant disrupts the p.Thr1210 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been observed in individuals with SCN1A-related conditions (PMID: 19350499), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2020 | The p.T1210M variant (also known as c.3629C>T), located in coding exon 18 of the SCN1A gene, results from a C to T substitution at nucleotide position 3629. The threonine at codon 1210 is replaced by methionine, an amino acid with similar properties. This alteration was detected in an individual with febrile seizures as well as in her unaffected father (Cetica V et al. Neurology, 2017 Mar;88:1037-1044). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at